Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
ZTE MF283U 4G Unlocked Router (Used)
ayanthamaxi
Updated:
Sunday at 8:26 PM
ලංකාවේ හොඳම උපකාරක පන්ති සහ ගුරුවරුන් එකම තැනකින් - TopTuition.lk
dulithapathum
Updated:
Saturday at 8:07 AM
Colombo
RidhMathraa ’26 🎶✨
Tmadhusanka
Updated:
Wednesday at 11:58 PM
Ad icon
Colombo
PXN V10 Pro Direct Drive Racing Wheel (Under Warranty)
Abdur Rahman
Updated:
Wednesday at 10:23 PM
Ad icon
USDT ණය සේවාව - USDT Loan Service
පුරවැසියා
Updated:
Wednesday at 4:54 PM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
Early Lung Cancer Detection - Nanosensors by MIT.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 29496327" data-attributes="member: 562115"><p>Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.</p><p></p><p>The new diagnostic is based on nanosensors that can be delivered by an inhaler or a nebulizer. If the sensors encounter cancer-linked proteins in the lungs, they produce a signal that accumulates in the urine, where it can be detected with a simple paper test strip.</p><p></p><p>This approach could potentially replace or supplement the current gold standard for diagnosing lung cancer, low-dose computed tomography (CT). It could have an especially significant impact in low- and middle-income countries that don't have <strong>widespread availability of CT scanners</strong>, the researchers say.</p><p></p><p>These sensors consist of polymer nanoparticles coated with a reporter, such as a DNA barcode, that is cleaved from the particle when the sensor encounters enzymes called proteases, which are often overactive in tumors. Those reporters eventually accumulate in the urine and are excreted from the body.</p><p></p><p>Previous versions of the sensors, which targeted other cancer sites such as the liver and ovaries, were designed to be given intravenously. For lung cancer diagnosis, the researchers wanted to create a version that could be inhaled, which could make it easier to deploy in lower resource settings.</p><p></p><p>Also Phase I trials for a similar sensor for use in diagnosing liver cancer and a form of hepatitis known as nonalcoholic steatohepatitis (NASH) is already on the way.</p></blockquote><p></p>
[QUOTE="imhotep, post: 29496327, member: 562115"] Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present. The new diagnostic is based on nanosensors that can be delivered by an inhaler or a nebulizer. If the sensors encounter cancer-linked proteins in the lungs, they produce a signal that accumulates in the urine, where it can be detected with a simple paper test strip. This approach could potentially replace or supplement the current gold standard for diagnosing lung cancer, low-dose computed tomography (CT). It could have an especially significant impact in low- and middle-income countries that don't have [B]widespread availability of CT scanners[/B], the researchers say. These sensors consist of polymer nanoparticles coated with a reporter, such as a DNA barcode, that is cleaved from the particle when the sensor encounters enzymes called proteases, which are often overactive in tumors. Those reporters eventually accumulate in the urine and are excreted from the body. Previous versions of the sensors, which targeted other cancer sites such as the liver and ovaries, were designed to be given intravenously. For lung cancer diagnosis, the researchers wanted to create a version that could be inhaled, which could make it easier to deploy in lower resource settings. Also Phase I trials for a similar sensor for use in diagnosing liver cancer and a form of hepatitis known as nonalcoholic steatohepatitis (NASH) is already on the way. [/QUOTE]
Insert quotes…
Verification
Hathara warak wissa keeyada? (Hathara wadi karanna 20)
Post reply
Top
Bottom